Renwei Jing
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Extracellular vesicles in disease 4
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Bingfeng Zuo (7 shared papers)HaiFang Yin (8 shared papers)Xianjun Gao (5 shared papers)Qi Han (4 shared papers)Zhen Lu (4 shared papers)Zhili Liu (2 shared papers)Quan Rao (3 shared papers)Hongxing Guo (1 shared paper)
In The Last Decade
Renwei Jing
16 papers receiving 708 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 291
- Immunology 272
- Molecular Biology 576
- Hepatology 36
- Oncology 96
Countries citing papers authored by Renwei Jing
This map shows the geographic impact of Renwei Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renwei Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renwei Jing more than expected).
Fields of papers citing papers by Renwei Jing
This network shows the impact of papers produced by Renwei Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renwei Jing. The network helps show where Renwei Jing may publish in the future.
Co-authors
The 25 scholars most cited alongside Renwei Jing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 332 | |
| 2 | 2020 | 137 | |
| 3 | 2022 | 118 | |
| 4 | 2020 | 27 | |
| 5 | 2018 | 16 | |
| 6 | 2024 | 15 | |
| 7 | 2022 | 15 | |
| 8 | 2013 | 11 | |
| 9 | 2018 | 9 | |
| 10 | 2019 | 8 | |
| 11 | 2014 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 4 | |
| 15 | 2025 | 1 | |
| 16 | 2013 | 1 |
About Renwei Jing
Renwei Jing is a scholar working on Molecular Biology, Immunology, Cell Biology, Surgery and Sensory Systems, having authored 16 papers that have together received 715 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (4 papers), Immunotherapy and Immune Responses (4 papers), melanin and skin pigmentation (4 papers), MicroRNA in disease regulation (2 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer Research and Treatments (2 papers), Olfactory and Sensory Function Studies (2 papers) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Cancer Research (291 citations), Immunology (272 citations), Molecular Biology (576 citations), Hepatology (36 citations) and Oncology (96 citations). Renwei Jing has collaborated with scholars based in China, Singapore and Thailand. Frequent co-authors include Bingfeng Zuo, HaiFang Yin, Xianjun Gao, Qi Han, Zhen Lu, Zhili Liu, Quan Rao, Hongxing Guo, Rong Yang and Qibing Zhou. Their work appears in journals such as Experimental Eye Research, Journal of Hepatology, Nature Communications, Cell Discovery and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.